Taking on melanoma, one cell at a time
In step toward personalized medicine, researchers are using single-cell analysis to unravel cancer’s secrets.
Scientific art lights up Main Street
Art and science converge in the public galleries at MIT's Koch Institute for Integrative Cancer Research.
Why some tumors withstand treatment
Researchers uncover a mechanism that allows cancer cells to evade targeted therapies.
Paving the way for metastasis
Cancer cells remodel their environment to make it easier to reach nearby blood vessels.
How cancer cells fuel their growth
Scientists surprised to find amino acids, not sugar, supply most building blocks for tumor cells.
How diet influences colon cancer
Study ties high-fat diet to changes in intestinal stem cells, may help explain increased cancer risk.
MIT senior takes on double major in brain and cognitive sciences plus theater arts
Abra Shen pursues medicine and theater, and someday hopes to combine the two.
Targeting cancer from many angles
Killian Award recipient Tyler Jacks fosters interdisciplinary, innovative cancer research.
Tracing a cellular family tree
New technique allows tracking of gene expression over generations of cells as they specialize.
Scientists discover how cancer cells escape blood vessels
Study offers new targets for drugs that may prevent cancer from spreading.
A new way to deliver microRNAs for cancer treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
M+Visión Fellow Carlos Castro named one of Spain’s top young innovators
Postdoc researcher recognized for leukemia management innovation.
Tackling cancer research from multiple perspectives
Graduate student Tushar Kamath takes an interdisciplinary approach to cancer research.
$20 million Commonwealth Foundation for Cancer Research gift to expand collaborative cancer research
Gift will augment the Bridge Project, a collaborative project between the Dana-Farber/Harvard Cancer Center and MIT's Koch Institute.
Biologists unravel drug-resistance mechanism in tumor cells
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.